Does DAPTOMYCIN Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with DAPTOMYCIN (daptomycin). This represents 0.1% of all adverse event reports for DAPTOMYCIN.
6
Reports of Malignant neoplasm progression with DAPTOMYCIN
0.1%
of all DAPTOMYCIN reports
4
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DAPTOMYCIN?
Of the 6 reports, 4 (66.7%) resulted in death, 4 (66.7%) required hospitalization, and 3 (50.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DAPTOMYCIN Cause?
Off label use (791)
Drug ineffective (658)
Product use in unapproved indication (654)
Eosinophilic pneumonia (575)
Acute kidney injury (501)
Blood creatine phosphokinase increased (461)
Pyrexia (447)
Eosinophilia (405)
Rhabdomyolysis (383)
Drug reaction with eosinophilia and systemic symptoms (307)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DAPTOMYCIN Alternatives Have Lower Malignant neoplasm progression Risk?
DAPTOMYCIN vs DARATUMUMAB
DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ
DAPTOMYCIN vs DARBEPOETIN ALFA
DAPTOMYCIN vs DARIDOREXANT
DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE